ClinicalTrials.gg
CompletedNCT04343950M-TICSUpdated Sep 24, 2025

SMS Messaging as a Tool to Improve Cancer Screening Programs

An interventional study of SMS reminders to enhance colorectal cancer screening and SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening: in Mass Screening, Colorectal Cancer and Breast Cancer, sponsored by Institut Català d'Oncologia. Completed at 1 site in Spain. Open to participants aged 50 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-24.

Sponsored by Institut Català d'Oncologia · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44,601
Allocation
Randomized
Ages
50 Years to 69 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 463 studies in Colorectal Neoplasms with a site in Spain — 97 open to participants now, 150 under way, 18 of them phase 3. Colorectal Neoplasms · Spain.

Enrollment
2nd of 405
44,601 · median 167
Started
2021
with 39 others
No phase
61 of 463
11 open now
Registered
254th of 463
by date

Among the 463 studies in Colorectal Neoplasms with a site in Spain, this one is the 2nd largest by enrollment of the 405 interventional ones that give a count, is one of 40 that started in 2021, is one of 61 with no phase, and was the 254th registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

97 of the 463 studies in Colorectal Neoplasms with a site in Spain are open now. Recruiting first, the newest first:

92 more — sign in →

All 97 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 50 Years to 69 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 463 studies in Colorectal Neoplasms with a site in Spain, or all of them as a file.
02

Study summary

The aim of this project is to assess the impact on health and economics of the implementation of text messaging (SMS) in cancer screening programs. Three interventions with SMS will be evaluated through community trials. In the colorectal cancer screening program the following interventions will be tested: a) Participation reminder: six weeks after sending the invitation letter of the colorectal cancer program if there has not been a response, a reminder SMS will be sent in front of the usual method by letter; b) Reminder to return the fecal occult blood test: SMS reminder of test delivery versus no intervention. This reminder will be sent to the individuals who have gone to the pharmacy to pick up a fecal occult blood test and they have not returned it after 14 days. The impact on participation will be analyzed and, if applicable, the proportion of advanced neoplasms will be calculated by increase in participation. In the breast cancer screening program, the invitation by SMS versus the usual invitation by letter will be studied in women who had participated in the previous screening round. The impact on participation will be analyzed. A cost-effectiveness analysis of the three interventions will be carried out. The incremental cost ratio of the interventions between cost variation and effectiveness variation will be calculated.

Read the detailed description

Main Hypothesis:

The implementation of SMS in population-based cancer screening programs will improve participation, especially in colorectal cancer screening, will allow a better resource management and reduce costs in both programs.

Specific Hypothesis:

Sending the reminder SMS will have an impact on participation greater than that obtained with the standard reminder (letter) in the colorectal cancer screening program.

The effect of the colorectal cancer screening reminder SMS will be greater among the individuals who have been invited for the first time and not previous participants.

Participation after receiving the invitation by SMS in breast cancer screening will be equal to or better than the letter invitation.

The alternative that includes sending SMS will be cost-effective in relation to the current alternative that you use postal shipping.

03

Conditions studied

  • Mass Screening
  • Colorectal Cancer
  • Breast Cancer

Keywords

  • Uptake
  • Participation
  • Cost-effectiveness
  • Breast cancer screening
  • Colorectal cancer screening
  • Text-message
  • Mobile-health
04

Who can participate

Ages eligible
50 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible individuals for colorectal cancer screening (intervention 1 and 2)
  • Eligible women for breast cancer screening (intervention 3)
  • Registered at the HealthCare Database (RCA)

Exclusion criteria

Exclusion Criteria:

  • Individuals without a mobile phone number registered at the RCA
  • Opt out from breast cancer screening and/or colorectal cancer screening
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44,601 participants (actual)

Study arms

  • Experimental
    Intervention 1: SMS reminders in colorectal cancer screening

    SMS reminders will be sent to individuals who received an invitation letter from Colorectal Cancer Screening Program and haven't participated within 6 weeks.

    Behavioral: SMS reminders to enhance colorectal cancer screening

  • Active comparator
    Usual Care 1: Reminder letter in colorectal cancer screening

    Reminder letters will be sent to individuals who received an invitation letter from the Colorectal Cancer Screening Program and haven't participated within 6 weeks.

    Behavioral: SMS reminders to enhance colorectal cancer screening

  • Experimental
    Intervention 2: SMS reminders to return the screening test

    SMS reminders will be sent to individuals who picked the fecal immunochemical test at the pharmacy and haven't returned it within 14 days.

    Behavioral: SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:

  • Active comparator
    Usual Care 2: No intervention

    No reminders will be sent.

    Behavioral: SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:

  • Experimental
    Intervention 3: SMS invitation among prior participants

    Invitation by SMS will be sent to women who previously participated in the Breast Cancer Screening Program.

    Behavioral: Invitation by SMS to previous participants in breast cancer screening:

  • Active comparator
    Usual Care 3: Invitation letter

    Letter invitations will be sent.

    Behavioral: Invitation by SMS to previous participants in breast cancer screening:

Interventions

  • BehavioralSMS reminders to enhance colorectal cancer screening

    Individual randomization will be used. Individuals assigned to the experimental arm with a wrong phone number will get a reminder letter (protocol analysis).

    Also known as: Intervention 1

  • BehavioralSMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:

    Individual randomization will be used. Individuals with a wrong phone number assigned to the experimental arm will not get any reminder (protocol analysis).

    Also known as: Intervention 2

  • BehavioralInvitation by SMS to previous participants in breast cancer screening:

    Individual randomization. Women assigned to the experimental arm and with a wrong phone number will get an invitation letter (protocol analysis).

    Also known as: Intervention 3

06

What researchers measure

Primary outcomes

  1. Intervention 1: Participation in colorectal cancer screening program

    Participation (no/yes) will be gathered prospectively 18 weeks after sending the screening invitation letter (week 0).

    Time frame: 18 weeks

  2. Intervention 2: Participation in colorectal cancer screening program among individuals who pick the test at the pharmacy

    Participation (no/yes) among those individuals who pick the screening test for colorectal cancer at the pharmacy 18 weeks after sending the screening invitation letter (week 0).

    Time frame: 18 weeks

  3. Intervention 3: Participation in breast cancer screening program

    Participation (no/yes) will be gathered prospectively 8 weeks after sending the screening invitation letter (week 0).

    Time frame: 8 weeks

Secondary outcomes

  1. Incremental cost ratio

    A cost-effectiveness analysis of the three interventions will be carried out. The incremental cost ratio of the interventions between cost variation and effectiveness variation will be calculated.

    Time frame: 18 weeks

07

Study locations

1 site
  • Institut Català d'Oncologia
    L'Hospitalet de Llobregat, Barcelona 08908, Spain
08

References and documents

Publications

  • Vives N, Farre A, Ibanez-Sanz G, Vidal C, Binefa G, Mila N, Perez-Lacasta MJ, Travier N, Benito L, Espinas JA, Bagaria G, Garcia M. Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol. PLoS One. 2021 Jan 22;16(1):e0245806. doi: 10.1371/journal.pone.0245806. eCollection 2021. PubMed 33481914 ↗
  • Vives N, Binefa G, Travier N, Farre A, Panera JA, Casas B, Vidal C, Ibanez-Sanz G, Garcia M; M-TICS research group. Text Messaging Versus Postal Reminders to Improve Participation in a Colorectal Cancer Screening Program: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2025 Jan 1;13:e64243. doi: 10.2196/64243. PubMed 39742454 ↗
  • Vives N, Vidal C, de Guzman EN, Farre A, Panera JA, Binefa G, Garcia M; M-TICS research group. The use of text messages as an alternative invitation method for breast cancer screening: A randomized controlled trial (M-TICS study). PLoS One. 2024 Aug 29;19(8):e0306720. doi: 10.1371/journal.pone.0306720. eCollection 2024. PubMed 39208325 ↗
  • Vives N, Travier N, Farre A, Binefa G, Vidal C, Perez Lacasta MJ, Ibanez-Sanz G, Nino de Guzman EP, Panera JA, Garcia M; M-TICS Research Group. Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study). JMIR Public Health Surveill. 2024 Jul 31;10:e57959. doi: 10.2196/57959. PubMed 39083331 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2021 to primary completion in Oct 2022, 16 months.

Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's 16 months is below that.

Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 9, 2020
First posted
Apr 14, 2020
StartActual
Jun 5, 2021
Primary completionActual
Oct 31, 2022
CompletionActual
Dec 31, 2022
Last update
Sep 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04343950
Lead sponsor
Institut Català d'Oncologia
Collaborators
University of Dundee, University of Barcelona, University Rovira i Virgili
Responsible party
Sponsor
First posted
Apr 14, 2020
Start date
Jun 5, 2021
Primary completion
Oct 31, 2022
Completion
Dec 31, 2022
Last update
Sep 24, 2025

Study contacts

Montse Garcia, PhD
principal investigator · Institut Català d'Oncologia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion